levobunolol hydrochloride

le·vo·bu·no·lol hydrochloride (lv-byn-lôl)

n.

A beta-blocker administered as eyedrops for the treatment of chronic open-angle glaucoma and ocular hypertension.

---

levobunolol hydrochloride

[-bun′əlol]

a topical ophthalmic beta-adrenergic blocker drug for glaucoma.

indications It is prescribed for the treatment of chronic open-angle glaucoma and ocular hypertension.

contraindications It is contraindicated for patients with bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second- or third-degree atrioventricular block, overt cardiac failure, or cardiogenic shock.

adverse effects Adverse effects may include transient ocular burning or stinging, bradycardia, pulmonary edema, and blepharoconjunctivitis.

---

levobunolol hydrochloride

(lev´ōbū´nōlol hī´drōklor´ād),
n brand name: Akbeta, Betagan C Cap BID, Betagan C Cap QD, Betagan Standard;
drug class: β-adrenergic blocker;
action: reduces production of aqueous humor by unknown mechanisms;
uses: chronic open-angle glaucoma, ocular hypertension.

---

beta-blocker 

A drug that blocks or reduces the action of neurotransmitters on beta-adrenergic receptors. It reduces secretion of aqueous humour and consequently intraocular pressure and it is used in the treatment of glaucoma. Common beta-blockers include timolol maleate, betaxolol hydrochloride, carteolol hydrochloride, levobunolol hydrochloride and metipranolol. Timolol is often used together with another agent (combination drugs), e.g. timolol and brimonidine, timolol and dorzolamide, timolol and latanoprost. Syn. beta-adrenergic antagonist; beta-adrenergic blocking agent. See adrenergic receptors; miotics; sympatholytic drugs.